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FOREWORD

Randomization in health and medical research of entire social units to experimental arms as occurs in ‘cluster’
randomized trials (CRTs) presents researchers, ethics committees, participants and evidence users with
ethical issues quite unlike those of conventional randomized control trials (RCT) in which the individual is
randomized and their right to give free, prior and informed consent is readily protected. By contrast, units of
randomisation, intervention and outcome measurement are different in CRTs. Clearly determining who are
research participants and establishing whose consent is required - not only for recruitment and intervention
but also data collection - are correspondingly difficult.
Aboriginal and Torres Strait Islander peoples in Australia reside in, react to and resist ongoing colonisation
and daily manifestations of health inequity due to their continuing marginalization, denial of rights and
dispossession. Australian ethical research guidelines informed by Aboriginal and Torres Strait Islander
perspectives assist researchers to negotiate within these structural conditions, ensuring that the rights of
Aboriginal and Torres Strait Islander research participants are not compromised. Yet none of these guidelines
currently contains explicit guidance for ethical conduct of CRTs in which entire communities or essential
services upon which Aboriginal and Torres Strait Islander peoples rely are randomized as occurs in the CRT
design.
This timely systematic review has produced a unique overview of ethical practices self-reported in publications
of CRTs conducted in Aboriginal and Torres Strait Islander settings published since 2008. Social units such
as schools or local primary health care serving Aboriginal and Torres Strait Islander peoples and even entire
communities have been randomized to intervention or control arms in experimental trials. This systematic
review also documents how researchers justified their use of the CRT design, the process of obtaining cluster
permission, intervention targets and concomitant consent, and approaches to primary outcome measurement
and consent for data collection.
Published by the Nulungu Research Institute, this review presents a methodically produced snapshot of
self-described ethical practices as at December 2020 as a baseline with which independent Aboriginal and
Torres Strait Islander human research ethics committees can develop CRT-specific guidance for their contexts.
Randomisation to experimentation of clusters of Aboriginal and Torres Strait Islander peoples or services upon
which they rely as occurs in CRTs behoves careful consideration.
Ms Vicki O’Donnell
Chair, WA Aboriginal Health Ethics Committee
Aboriginal Health Council of Western Australia
September 2021
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EXECUTIVE SUMMARY
Cluster randomised trials (CRTs) present unique ethical
complexities for research ethics committees, participants,
researchers and evidence users. In this design, whole
social units (‘clusters’) such as hospitals, schools or
entire communities are randomised to interventions.
In addition, units of randomisation, intervention and
outcome measurement differ within the one study. As a
consequence, clearly determining research participants
and establishing whose consent is required not only for
randomisation and interventions but also data collection
are correspondingly difficult.
This systematic review describes self-reported ethical
practices in research conducted in Australia in which
social units comprising Aboriginal and Torres Strait
Islander people, their communities or services upon
which they rely were randomised as whole clusters
to trial interventions. To undertake this systematic
review, we developed a study protocol and registered it
prospectively on a public database (PROSPERO protocol
CRD42018106463). Applying this protocol meant
we could methodically identify all CRTs conducted in
Aboriginal and Torres Strait Islander settings in Australia
by finding their peer-reviewed study protocols or articles
with main results reporting primary outcomes.
We identified 18 eligible CRTs published from January
2008 to December 2020. In six CRTs (33%), researchers
had randomised entire Aboriginal and Torres Strait
Islander communities. Other cluster types included
schools, stores and health services. Depending on study
design, community-based health services randomised
as clusters included mainstream practices, governmentmanaged clinics, Aboriginal and Torres Strait Islander
community-controlled health services or combinations of
these. Cluster level permission was documented for ten
CRTs (55%) although gatekeeper authority to give this
permission was not always explained in detail. Cluster
eligibility to participate in the CRT was based exclusively
on prior relationships in six CRTs (33%). Material
incentives from researchers to clusters or financial
payments to people within clusters ranged from none
to substantial. Three CRTs (17%) had obtained consent
waivers for individual informed consent. Grounds for
waivers were not always explained, including whether
they covered intervention participation only, access to
4

individual data without consent, or both. Of ten CRTs
(10%) requiring access to routinely collected individual
data for primary outcome measurement, one (10%)
obtained individual written consent. Approaches to
cultural safety and data sovereignty varied. For 11 (61%),
independent Aboriginal and Torres Strait Islander ethics
committee approval was obtained. Among the 18 CRTs,
seven (39%) were stepped-wedge CRTs in which all
clusters had been exposed by the end of the trial to an
untested intervention. Only five (39%) of the 13 CRTs with
published main results produced statistically significant
impact on health outcomes.
This systematic review of 18 CRTs from 2008 to the
present day reveals considerable variation in selfreported ethical practices for key features in CRT design.
This variation invites specific effort in conjunction with
independent human research ethics committees to
strengthen conceptualisation and conduct of trials
in which large social units comprising Aboriginal and
Torres Strait Islander peoples or services they receive are
randomised as clusters with potential for both benefit
and harm.

INTRODUCTION
Key features of cluster randomised trials
(CRTs)
For more than a century, health and medical research has
used the conventional randomised controlled trial design
(RCT) as the foundation for testing the efficacy and harms
of individual clinical treatments. As is widely recognised,
RCTs

… are structured around the individual patient: the
patient is recruited and allocated independently to
either intervention or control arm, administered the
allocated intervention and observed prospectively.
This design is optimal in the sense that the number
of independent allocation units is the same as the
number of observations to be analyzed
(Taljaard & Grimshaw 2014:1)

This design is familiar and straightforward in terms of
its methodological architecture and secures meaningful
consent because randomization, intervention and data
collection implicate only the individual, and it is the
individual who is asked to participate and sign consent.
By contrast, cluster randomized trials (CRTs) differ
profoundly from individual RCTs because their defining
feature is randomization of entire ‘social units’ rather than
individuals are assigned randomly to trial arms. These
social units are known as ‘clusters’ and, depending on
the research, might be hospitals, schools, workplaces,
child care centres or social services for example.
Interventions to which these clusters are randomised
might target every individual in the cluster, only a
subset of individuals or, if the cluster is an organization
or service, staff intermediaries who work in the cluster
structure. CRTs have been used in diverse health settings
for research and evaluation purposes such as projects
to evaluate different models of health services delivery,
health promotion campaigns or interventions designed
to increase the uptake of evidence-based methods in
medical practice for example. It is entirely possible that
individuals in CRTs may be unaware of a randomized
experiment underway that might affect their outcomes
or their cluster’s social dynamic, functioning or social
capital.
There are three main CRT types. Of these, the most
common is a parallel arm CRT in which clusters
are randomized to either intervention or control
groups. Here, control group clusters will not receive
the intervention as part of the CRT. Occasionally,
mechanisms might be in place following the
demonstration of positive impact to deliver the
intervention to those on hold as wait-list controls. In
cross-over CRTs, clusters are exposed to two or more
interventions being compared: for example, a 2x2 crossover CRT will randomize half of the clusters to receive
intervention A followed by intervention B, while the
other half receive intervention B followed by intervention
A. The third type is known as the stepped-wedge CRT
(SW-CRT). In this type of CRT, the intervention is delivered
to every cluster in a sequence of steps determined by
randomization so that, by intention, all clusters eventually
receive it (Campbell et al 2019).

RCTs compared with CRTs: key ethical
differences
Human research ethics committees (HRECs) determine
whether risks to people invited to participate in health
research are minimized consistent with sound scientific
design. Knowledge gained must outweigh risks (Weijer et
al 2011). Three ethical principles are widely accepted and
applied to make such determinations, namely respect for
persons, beneficence and justice. As reviewed elsewhere

the principle of respect for persons … requires that
individual autonomy be acknowledged and that
persons with diminished autonomy be protected;
the principle of beneficence … requires that persons
not only be protected from harm, but also that
steps be taken to ensure their well-being; while the
principle of justice …refers to the fair distribution
of goods; in the context of research, it refers to the
equitable distribution of the risks and potential
benefits of research participation (Weijer 1999:503).
Additional principles for health and medical research
proposals involving communities have also been
proposed (Weijer & Emanuel 2000).
As described earlier, CRTs bring inherent risk for social
units and the individuals within these social units.
Assessment of benefits and harms in CRTs is not as
straightforward as in RCTs (Taljaard & Grimshaw 2014).
In an RCT, the state of equipoise and the rationale for
inviting individuals to participate in a RCT can be readily
communicated to each potential participant one by
one in consent procedures. What participants can
expect and their agency in an RCT including access to
their health data is also clearly conveyed in participant
information prior to consent. By contrast, the moral
rights of social units in CRTs are less easily defined and
harder to operationalise. Gauging true equipoise is
more challenging (Hey et al 2018; Hemming et al 2018).
Nonetheless,

CRTs should be conducted in accord with
appropriate scientific and ethical principles
(Hemming et al 2018:664)
5

CRTs

raise distinct ethical challenges that may require
more thought and time at the protocol development
and research ethics application stages. The
decision to adopt cluster rather than individual
randomization should therefore not be made lightly
(Taljaard & Grimshaw 2014:1)
Ethical obligations require a ‘cluster gatekeeper’ of whom
researchers will gain permission for cluster participation
in a CRT. However, the identities and authorities of such
gatekeepers to act on behalf of the cluster in this way
may be unclear or contestable. In CRTs, gatekeepers
could be individuals, Chief Executive Officers (CEOs),
boards or councils authorized through agreed means
- such as elections or corporate appointments with
delegations - to speak on behalf of their respective
cluster and legitimately assert cluster interests.
In addition, multi-level interventions in various
combinations can similarly make the identification
of research participants unclear and mechanisms for
intervention consent challenging. Researchers must
obtain free, prior and informed consent from anyone
exposed to the intervention and anyone with whom the
researcher interacts for the purpose of collecting data or
anyone whose identifiable information is obtained as part
of research conduct unless a waiver of consent is sought
and granted by an appropriately constituted research
ethics committee. In CRTs however, interventions
introduced by researchers might target the cluster as a
whole, all individuals who make up the cluster or only a
subgroup of individuals (Taljaard & Grimshaw 2014). If
the cluster is an organization or service, staff might be
targeted for interventions but with consequences for
users of the organization or service.
IIn health research, outcome measurement in CRTs
adds further complexity for ethical appraisal (Taljaard
& Grimshaw 2014; Campbell et al 2019). Quantitative
measures to analyse the primary outcome for which the
CRT is designed might require data collection directly
from individual participants using specific measures such
as surveys or accessed via routinely collected clinical
information as contained in a clinical record with or
without the individual’s knowledge.
6

To summarise, the conventional RCT aligns allocation
to randomisation, receipt of intervention and unit
of observation and analysis to the same entity - the
individual - in a relatively uncomplicated fashion.
Informed consent is individualistic. In CRTs, it may not
be immediately easy to discern from whom consent
is required after randomization and whether for
intervention, data collection or both (Weijer et al 2011).
The foundation of international biomedical ethics is that
every research ethics committee must minimize risks
to potential research participants by considering the
soundness of the proposed scientific design and ensure
that knowledge gained will outweigh risks (CIOMS 2016).

‘Ottawa Statement’ on the ethical design
and conduct of cluster randomized trials
In 2012, a collaborative international academic team
published the ‘Ottawa Statement on the Ethical
Design and Conduct of Cluster Randomized Trials’
(Weijer et al 2012). This Ottawa Statement includes
15 recommendations on ethical aspects of CRTs
organized in seven domains including justification for
choosing cluster randomization rather than individual
randomisation, steps to identify research participants,
obtaining gatekeeper permission for randomization of
an entire cluster, evaluating mechanisms for informed
individual consent for interventions, and assessing ethical
requirements for data collection and individual consent
for outcome measures. Contextualised grounds for
granting waivers in CRTs are also described in the Ottawa
Statement (Weijer et al 2012).

CRTs affecting Aboriginal and Torres
Strait Islander peoples
Aboriginal and Torres Strait Islander leaders and scholars
have long argued about the unique ethical issues
inherent in research conducted in Australia, particularly
when studies are led by or disproportionately advantage
non-Indigenous research institutions or researchers
(Wyatt 1991; Schnarch 2004; Thomas & Anderson
2006; Jamieson et al 2012; Bainbridge et al 2015).
Throughout Australia, histories of colonization have left
an indelible mark on Indigenous health (Anderson et
al 2006; Paradies 2016). By acknowledging this wider

political context in Australia, research and its ethical
conduct abuts the overarching powers of the ‘settler
state’ in which Aboriginal and Torres Strait Islander
peoples have been and continue to be systematically
marginalized and disempowered (Ninomiya & Pollock
2017; Rigney 1999; McPhail-Bell et al 2018; Rix et al 2018;
Benveniste & King 2018). In Australia, declaration of
terra nullius by Governor Bourke in 1835 masked the
truth that Aboriginal and Torres Strait Islander peoples
never ceded their sovereignty or relationship to country
and waters to the British crown. Prosperity and reempowerment of Aboriginal and Torres Strait Islander
communities requires strong culture, nation-rebuilding
and relationship to land and waters defined in their own
terms (Yu 1994; Arabena 2006; AIATSIS 2012; Pearson
2012; Dwyer 2012).
Aboriginal and Torres Strait Islander communities and
organisations are complex socio-political environments,
and priorities for research focus may vary between
members and/or within organizational Boards. Deeper
considerations of ethical research practice in these
environments must account for the possibility of
alterity within the community – of nonconforming, or
unrepresented others: there are always ‘groups with
groups’ (Sullivan 2020). As with any form of pseudorepresentation, the use of gatekeepers in these contexts
might represent a superficial or unreliable form of
permission-giving for the entire cluster.

CRTs conducted in Australian Aboriginal and Torres Strait
Islander settings. This systematic review was conducted
with the specific aims of ascertaining the types of
clusters randomized in these CRTs and documenting
ethical practices with respect to design justification,
cluster permission, intervention levels and consent, and
approaches to primary outcome measurement. Despite
their ethical complexity, such a snapshot has not before
been produced.

METHODS
We developed and then registered our protocol for this
systematic review prospectively with the PROSPERO
register (CRD42018106463) where details about our
adherence to Cochrane and PRISMA requirements are
provided (Ward et al 2018).
To determine eligibility for inclusion in our systematic
review, we applied the definition of a CRT as presented in
the Ottawa Statement as follows:

A study design that randomizes to different study
arms groups or clusters of individuals (such as
households, primary care practices, hospital wards,
classrooms, neighbourhoods or communities),
rather than independent individuals. Another
distinguishing feature of CRTs is that the units of
allocation, intervention, observation, and analysis
may be different within a single study. CRTs may
also be referred to as group randomized, place
randomized, or community intervention trials
(Weijer et al 2012:S3).

Randomisation of clusters of Aboriginal and Torres Strait
Islander peoples or services upon which they rely to
experimentation as undertaken in CRTs behoves careful
ethical consideration. While Australian ethical research
guidelines informed by Aboriginal and Torres Strait
Islander perspectives exist (NAILSMA 2007; Lincoln et
al 2017; Taafe 2008; Laycock et al 2011; NHMRC 2018;
Fitzpatrick et al 2019; Lovett et al 2019; AIATSIS 2020;
AHMRC 2020), none to date contains explicit guidance for
ethical conduct of CRTs. Although the only international
guidance for CRTs, the Ottawa Statement was developed
without the explicit participation of First Nations
Canadians, Aboriginal and Torres Strait Islander peoples,
Maori or other Indigenous representatives.

Study methods of potential Australian CRTs needed to
describe and randomly allocate social units of Aboriginal
and/or Torres Strait Islander people or organisations
directly serving them for inclusion in our systematic
review. Our time period was pre-specified from 2008 to
2020 to provide 12 years of research output including
a reasonable period to assess uptake in Australia of the
Ottawa Statement published in 2012.

In this context, our multidisciplinary team of six research
collaborators came together to summarise self-reported
ethical practices as described in research publications for

To generate the largest possible pool of potential
Australian CRTs, we adapted previous search strategies
(Taljaard et al 2010; Siebenhofer et al 2016). We
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searched five electronic databases for eligible studies,
namely: MEDLINE (Medicine / Nursing / Dentistry /
Preclinical Science), PREMEDLINE, Embase (Biomedical/
Pharmaceutical / Health Policy / Nursing), PsycINFO
(Psychology / Education/ Behaviour) and EMCARE
(Nursing / Allied Health). Precision was enhanced by
including cluster design-related term using the Boolean
operator AND (Taljaard et al 2010). Box 1 presents
our search strategy for MEDLINE. For other databases,
BOX 1 – Example of search strategy (Medline)
Database: MEDLINE(R) including Daily update <1996-current>
Search Strategy:
-------------------------------------------------------------------------------1 randomized controlled trial/ (410254)
2 animals/ (3896408)
3 humans/ (11450181)
4 2 not (2 and 3) (2487387)
5 1 not 4 (399299)
6 (cluster$ adj2 randomi$).tw. (9815)
7 ((communit$ adj2 intervention$) or (communit$ adj2
randomi$)).tw. (6413)
8 group$ randomi$.tw. (2771)
9 6 or 7 or 8 (18462)
10 intervention?.tw. (707732)
11 cluster analysis/ (59684)
12 health promotion/ (61847)
13 program evaluation/ (55871)
14 health education/ (32254)
15 10 or 11 or 12 or 13 or 14 (861112)
16 9 or 15 (864232)
17 5 and 16 (94672)
18 aboriginal$.ab. (5585)
19 indigenous.ab. (19986)
20 18 or 19 (24426)
21 17 and 20 (151)
22 limit 21 to (english language and yr=”2008 -Current”)
(127)
“$” allows for truncation of words so that variations such as
“randomisation”, “randomization” are included;
“Adj” refers to the adjacency operator to accommodate terms
such as “community-based randomized trial”;
“pt” refers to publication type
“?” refers to optional wildcard character retrieving 1 or 0
characters;
“/” refers to MeSH
“tx” refers to text words in the title or abstract
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we modified if necessary. To address the variation in
spelling of ‘randomized’ or ‘randomised’, our search
strategy used the $ sign to encompass both. Two authors
independently examined titles, abstracts and full text for
retrieved citations. Only CRTs with peer-reviewed study
protocols or main results publications were included in
our final sample for detailed review. Studies using nonrandomized assignment of clusters to interventions were
excluded. Disagreements in eligibility were noted and
resolved. We also searched the Australian New Zealand
Clinical Trial Registry (ANZCTR). Any CRT with ANZCTR
registration but without either published study protocol
or main results article was noted for future reference but
excluded from this review. For any CRT with a published
study protocol, we continued to search monthly for main
results until December 2020.
To extract information from each publication, we adapted
an earlier data template (Taljaard et al 2011). We used
this adapted template to extract data consistently
from every publication. For each CRT, we first referred
to the study protocol to extract details about cluster
design justification, cluster sampling and recruitment.
We documented how researchers had defined their
study ‘clusters’. We then extracted details about
cluster gatekeepers as described by the researchers,
governance structures and the process of requesting
and documenting gatekeeper permission. In Australia,
Aboriginal and Torres Strait Islander governance differs
by community according to factors such as history,
resources, relationships and capacity (Hunt et al 2008).
Therefore, we also noted any statement made by
researchers about community governance, implications
for cluster permission and details of those described
as gatekeepers. Because units of randomization,
experimentation, and outcome measures differ within
the one CRT study, we carefully abstracted information
about intervention levels and corresponding participant
consent, incentives, consent for data collection for
primary outcome measurement, and any relevant detail
about data management and relationships already
existing or developed during the CRT by researchers
with Aboriginal and Torres Strait Islander peoples. Where
there was no study protocol, we used the main results
article to extract the above details. If both were available,
we double-checked ethical practices reported in both,
synthesizing both sources and noting any discrepancies.

Because this was a systematic review of content in open
access articles already in the public domain, institutional
ethics committee approval was not required. As no
external funding was obtained for this review, we were
unable to contact study authors. This also precluded any
further follow-up to identify Aboriginal and Torres Strait
Islander authors unless included in the retrieved articles.

RESULTS
Sources of CRTs identified in this
systematic review
From 456 citations, 14 CRTs with either study protocol
or main results publications were obtained from the
electronic search method (Figure 1). Those 24 CRTs found
9

by searching ANZCTR comprised nine already identified
from the electronic literature search. Four registered CRTs
had published peer-reviewed study protocols and/or
main results articles. Adding these four from the ANZCTR
search to our electronic search yield, we identified 18
distinct CRTs randomising clusters as below:
•
Community-based primary care services meeting
the health needs of Aboriginal and Torres Strait Islander
peoples [CHS]: CHS1 (Schmidt et al 2012; McDermott et al
2015; Segal et al 2016); CHS2 (Peiris et al 2012; Peiris et al
2015); CHS3 (Guy et al 2013; Guy et al 2018); CHS4 (BarZeev et al 2017; Gould et al 2019); CHS5 Liaw et al 2019);
CHS6 (Harrison et al 2019) and CHS7 (Bradley et al 2020)
•
Entire communities [EC]: EC1 (Slade et al
2011); EC2 (Ward et al 2013; Ward et al 2019); EC3
(Brimblecombe et al 2013; Brimblecombe et al 2017); EC4
(Ralph et al 2016; Ralph et al 2018); EC5 (Arrow et al 2018;
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Arrow et al 2020) and EC6 (Mullane et al 2019).
•
Stores in remote communities [RS]: RS1
(Brimblecombe et al 2019; Brimblecombe et al 2020)
•
Schools [SCL]: SCL1 (Kiran & Knights 2010) and
SCL2 (Wagner et al 2017; Wagner et al 2020)
•

Households [HLD]: HLD1 (Borg et al 2018)

•

Hospitals [HPL]: HPL1 (McAulley et al 2016)

As shown in greater detail in Table 1, ten of these 18 CRTs
had both published study protocol and main results
article by December 2020; four had only a published
study protocol and four had been reported in the peerreviewed literature only as main results articles without
prior study protocols. Each CRT has been assigned a
unique label for reader convenience.

Types and locations of clusters
Across all of these 18 RCTs, we identified six distinct
categories of clusters (Table 1). In seven CRTs (39%),
researchers reported randomizing primary care
organisations serving Aboriginal and Torres Strait
Islander people (Table 1). Entire communities had been
randomized as clusters in six CRTs (33%)(Table 1). Other
clusters comprised birthing hospitals, schools, stores
and households (Table 1). Across 18 CRTs, the median
number of participating clusters per CRT was 20 (range
4–5,534)(Table 1). While two CRTs recruited only four
clusters each, one had recruited and randomized every
large Aboriginal community across a designated region
of interest [EC6] while the other had recruited and
randomised every school within a remote geographic
footprint known to be at high risk of service failure [SCL2].
In terms of design, more than a third (n=7, 39%) were
SW-CRTs. All (100%) had been approved by at least one
HREC (number of HRECs per CRT ranged from 1 to 8;
median 3). However, only 11 (61%) had been approved by
independent Aboriginal and Torres Strait Islander ethics
committee(s). NHMRC ethical guidelines for Aboriginal
and Torres Strait Islander research (2018) were cited by
four [CHS4, EC6, RS1 AND SCL2]. All but two CRTs (89%)
were funded entirely or in part by the NHMRC (Table 1).
Among the 12 CRTs published after release of the Ottawa
Statement, only one had cited it [ECS2]. Cited in the
study protocol, the Ottawa Statement was not used in

reference to ethical practices but to state that the design
allowed the intervention to be delivered to all clusters
and would likely have a potential beneficial effect [ECS2].

Justification of cluster design
All CRTs gave at least one justification for the choice of a
cluster randomized design (Table 2). While the strength
of these assertions could not be independently assessed
from publication details, the most common overall was
the necessity to deliver the intervention at entire clusterlevel. Four SW-CRTs explicitly stated that it was ethically
preferable that all clusters received their intervention
as part of their research offering [CHS4; CHS7; EC6;
HPL1]. Three of these prospectively distinguished
anticipated benefits as a reason not to withhold their
intervention from any cluster [CHS7; EC6; HPL1]. Four
SW-CRTs explicitly acknowledged their design choice was
preferable to other study choices specifically on ethical
grounds. One was affirmed as a preferred model with
stakeholders [EC2].
Other details revealed additional insight into design
choices. For one, [SCL2], the original design had been
proposed as a SW-CRT but stakeholder feedback
after earlier pilot testing rejected the SW-CRT design.
Researchers pursued a parallel CRT. In another, [CHS4],
researchers had conducted a SW-CRT design as
reported. As participating clusters had found the SWCRT confusing, all future research by this team would
no longer deploy this design as intended. In another,
11

the SW-CRT design was described in the main results
article as having been substantially modified from study
protocol [EC5].

Cluster recruitment, permission and
gatekeepers
Six (33%) CRTs used pre-existing relationships to
define sampling frames. In other words, eligibility for
cluster research participation had been predetermined
through familiarity, partnerships or earlier collaborations
[CHS4; CHS5; CHS7; EC3; EC5; RS1]. Five (28%) used
demographic, epidemiological or service criteria with or
without additional stakeholder consultation to identify
and approach clusters [CHS5; EC1; EC2; EC4; EC5].
Reproducible cluster recruitment strategies including
random selection from a sampling frame reduces CRT
bias. Six (33%) CRTs reported a priori relationships
that materially influenced their recruitment strategy
[CHS4; CHS5; CHS7; EC3; EC5; RS1]. Demographic,
epidemiological or service requirements were applied
in five (28%) CRTs although subsequent additional
stakeholder consultation may have diminished
generaliseability [CHS5; EC1; EC2; EC4; EC5].
Cluster permission was reported for 11 CRTs (61%)
although not always with clear information about the
corporate governance of respective clusters or scope of
permission (CHS2; CHS3; CHS5; CHS6; CHS7; EC1; EC2;
EC3; EC4; RS1). Where obtained, cluster permission was
documented in a variety of ways including research
agreements, site participation agreements, partnership
agreements and memoranda of understanding. It was
uncommon for the specific details of permission in
these documents to be stated or for the role held by
the signatory on behalf of the cluster to be described.
Community permission was conflated with service
consent in three [EC2; EC3; EC4]. Specifically, researchers
assumed service organizations could give cluster

permission on behalf of the entire community without
corroborating detail about the community’s specific
governance structures legitimizing this approach to
gatekeeper permission. Further, one CRT described
only meetings organized with the CEO of the respective
remote community council but no specific description of
cluster permission process [EC5].

Consent for study interventions and
incentives
Table 3 summarises intervention levels and their
combinations. Table 4 presents further details about
consent for interventions. Obtaining consent to
participate in interventions at professional level (usually
staff as intermediaries in clusters) or from individuals
exposed to interventions due to randomization was
less common than obtaining cluster permission. Of
13 CRTs delivering interventions to professional-level
intermediaries, only one reported obtaining their consent
[CHS7]. For those 13 CRTs where individuals were
targeted, individual consent for interventions was clearly
obtained in four (31%)[CHS4; EC1; EC5; SCL2]. In one CRT,
consent to participate was only obtained from individuals
in clusters randomized to intervention leaving those in
control clusters unaware [HPL1]. In another, individual
consent for service delivery changes was obtained only
for those being prescribed medication off-label as part of
this change [EC6]. Eight CRTs (44%) offered some kind of
financial reimbursement in recognition of costs for trial
participation, material incentive or benefit [CHS2; CHS3;
CHS4; CHS6; EC2; EC3; EC5; SCL2]. Two of these provided
payments to services tied to clinical performance [CHS3;
EC2]. Three (17%) CRTs described research employment
opportunities for local community members [EC3; EC5;
SCL2]. One (6%) CRT organized formal training [SCL2].
Seven of these eight CRTs (88%) had been reviewed by
at least one independently constituted Aboriginal and
Torres Strait Islander research ethics committee (Table 1).

Primary outcome measurement,
consent for data collection and safety
monitoring
Table 4 also shows primary outcomes, their levels of
data collection and consent. For two CRTs, the primary
outcome had been measured from routine sales data
and permission obtained from shop managers [EC3;
RS1] (Table 4). For the remaining 16 CRTs (89%), primary
outcome was measured at individual level (Table 4): six of
these developed bespoke measures outside routine data
capture while ten of these required access to routinely
collected data at individual level for primary outcome
measurement. One of these ten obtained individual
written consent [CHS7]. Waivers were obtained from
ethics committees for three CRTs [CHS2; EC4; HLD1].
For one of these however[CHS2], an ‘opt out’ option
was offered for individual data level access but only for
Aboriginal people seen in ACCHOs and no-one attending
mainstream general practices. Contradicting the waiver,
how this ‘opt out’ option was operationalized was not
described. Two CRTs (11%) mentioned the existence of
a Data Safety and Monitoring Board or similar to advise
researchers [CHS7; EC6]. CHS4 explained why such
was not needed. For 14 (78%), main results had been
published (Table 4). One did not have a quantifiable null
hypothesis [CHS4]. Five of the remaining 13 (39%) had
produced statistically significant results [EC1; EC3; EC5;
RS1; HLD1]. One of the four SW-CRTs with main results
had produced a statistically significant primary outcome
[EC3].

Aboriginal and Torres Strait Islander
sovereignty and veto
In six CRTs (33%), strategies that aimed to support
Aboriginal and Torres Strait Islander perspectives
including data governance were clearly described
for example an Indigenous Reference Group [EC1], a
Stakeholder and Consumer Aboriginal Advisory Panel
[CHS4] and an Aboriginal Advisory Group [EC5]. Terms
of reference were outlined or implied. Elders were more
commonly cited than Traditional Owners. CHS3 had
written principles of data ownership and processes for
public release of results. Two CRTs were self-described
in study protocols as ‘co-design’ [CHS7; RS1]. All CRTs
acknowledged extensive consultation prior to research
commencement but not always sufficient for replication
or improvement. Seeking feedback on drafted research
materials from a state-wide Aboriginal peak group
which was then incorporated where possible evoked
later criticism [HLD1](Crooks et al 2019). Table 1 also
presents the number of authors per CRT for protocol and/
or main result publication. None of the study protocols
or main result publications specified if any authors were
Aboriginal or Torres Strait Islander.

DISCUSSION
This systematic review identified 18 CRTs conducted
in Australia and published since 2008. By employing
a thorough search strategy comprising standardized
searches of electronic databases combined with ANZCTR
access, we conclude it is unlikely that we have missed any
CRTs in which communities where Aboriginal and Torres
Strait Islander peoples live or socially significant entities
such as schools, stores or health services upon which
they rely have been randomized to interventions. We
extracted publicly available self-reported ethical practices
from researchers’ peer-reviewed study protocols, main
results articles or, for ten CRTs, both. To our knowledge,
this systematic review is the first to furnish such a timely
overview.

What we learned
Ethical aspects of such CRTs are challenging to
understand. As shown, the units of randomization,
experimentation and observation may differ within
a single trial. Hence, it is not straightforward (as in
a conventional RCT) to determine who should be
considered a ‘research participant’. Equally important,
CRTs involve groups of people who are organized
as social units within the designated clusters. Their
relationships are bound by these clusters. Further,
neither the moral status of groups per se nor the rights
of individuals within these groups when randomized
in CRTs with or without their knowledge are well
understood. Hence, Weijer et al (2011:5) have declared
that CRTs ‘... only partly fit within the current paradigm
of research ethics’. They continue to articulate unique
ethical conundrums:

First, … the answers to pivotal ethical questions,
such as who may speak on behalf of a particular
group and on what authority they may do so,
are unclear. Second, in cluster trials the units of
randomization, experimentation, and observation
may differ, meaning, for instance, that the group that
receives the experimental intervention may not be
the same as the group from which data are collected
(Weijer et al 2011:5).

To inform and encourage dialogue about these ethical
dimensions as put into practice in CRTs, we highlight four
grouped findings regarding (1) context and rationale
(2) permission, consent and data (3) cultural authority
over design and (4) additional ethical aspect of SW-CRTs.
Overall, we note that all 18 CRTs had been reviewed
by at least one human research ethics committee, an
improvement over earlier international findings (Taljaard
et al 2017; Siebenhofer et al 2018; Taljaard et al 2020;
Al-Jaishi et al 2020; Prost et al 2015; Grayling et al 2017).
However, less than two thirds had been reviewed by an
independent Aboriginal and Torres Strait Islander HREC.

Context and rational
Reasons given for cluster randomization accorded
with findings of other systematic reviews of CRTs
conducted internationally (Taljaard et al 2011; Taljaard
et al 2017; Siebenhofer et al 2018). We also found
variation across these 18 CRTs in their sampling frames
to identify and recruit eligible clusters and methods
for obtaining cluster permission for interventions
prior to randomization. Pre-existing relationships predetermined the sampling frame for six CRTs (33%).
Although well-established before initiating research
implementation, their nature could have been better
described and the consequence for scientific validity
in deliberately confining eligibility to participate in the
CRT only to those with pre-existing relationships with
researchers better communicated. In five CRTs, nonrelational eligibility criteria were developed and applied
to maximize the number of clusters and sampling frame.
In this approach, bias is more readily assessed. In CRTs
conducted in remote locations, cluster randomization
meant that the community’s only accessible health
service, store or school was in a CRT. Pre-existing
relationships may have safeguarded against potential
harms from research activity. These relational conditions
for CRTs were intriguing and require further enquiry
beyond text abstraction to better understand and codify
for ethical review. In addition, it was not always clear
why randomization of entire ‘social units’ enhanced
intervention impact. As stated by Campbell (2019), the
CRT design should be avoided if the RCT design better
answers a research question about individual therapeutic
benefit unless there is concern about contamination.
While logistics and contamination were common reasons

for deploying the CRT design in these 18 CRTs, for others
there was either an implicit or explicit intent to engage
with clusters as social units as part of the intervention. Six
CRTs targeted all three levels (the cluster as a functional
unit plus the staff working within schools or health
services plus individual service recipients, students or
community members). For future CRTs randomizing
entire communities, there would be merit in further
investigating how cluster-level interventions could
be better informed by theories of community agency,
empowerment or co-design to maximize insights about
the importance of Aboriginal and Torres Strait Islander
community engagement in CRTs and future knowledge
transfer.

Permission, consent and data
Cluster gatekeepers are never in a position to provide
proxy consent on behalf of individual cluster members
(Weijer et al 2012). Details as abstracted from these 18
CRTs varied as to how the researchers explained their
proposed management of ethical complexities inherent
in the CRT design including multi-layered interventions,
exposures and measurements. Despite feasibility,
patterns of consent by level to participate in these CRTs
were highly variable.
Any research poorly conceptualized or disrespectfully
conducted with Aboriginal and Torres Strait Islander
peoples compromises cultural safety, community trust
and self-determination. Harms inadvertently introduced
by a CRT may extend beyond the life of the CRT itself. In
health service provision, cultural safety is conceptualised
as both an ethical standard of health care practice and
an outcome of the quality of care provided (Elvidge et
al 2020). When conducting research about Aboriginal
and Torres Strait Islander health, cultural safety could
span significant epistemic risks such as misrepresenting
or misappropriating what happened or was achieved
in any specific research study. For this reason, culturally
unsafe health and medical research can abet continuing
colonization through research activity of Aboriginal
and Torres Strait Islander peoples (Cameron et al 2010;
Jennings et al 2018; Mackean et al 2019; Bond et al 2021;
Sherwood et al 2020).

As described in the Ottawa Statement (Weijer et al
2012), gatekeepers are individuals or bodies who may
be called upon to protect the group-based interests
of the cluster that are affected by enrollment in a CRT.
They play an important role in the protection of cluster
interests but this responsibility can be met only when
they have legitimate authority. Criteria for identifying
gatekeepers are emerging (Weijer et al 2012). In these 18
CRTs we identified in this systematic review, procedures
to identify, inform and heed ‘gatekeepers’ appeared nonstandardised however. Expectations of researchers about
these ‘gatekeepers’ and the authority they hold on behalf
of individuals in their respective cluster were unclear.
There was little transparency regarding the role of Native
Title organisations including Prescribed Body Corporates
(PBCs), community-controlled service organisations
created under ORIC legislation or acknowledged Elders as
‘gatekeepers’ in these 18 CRTs. Gatekeepers ensure that
risks of participation in the CRT including randomization
are commensurate with the benefits for the cluster of the
proposed research (CIOMS 2016; Martin 2008).
Having obtained cluster permission, individual consent
for participating in interventions was lacking in almost
all of those CRTs with interventions targeting individual
participants. Researchers’ omitting to obtain individual
informed consent for interventions (or obtaining a
waiver) has been found elsewhere (Taljaard et al 2011;
Taljaard et al 2017). Furthermore, consent for data
access was similarly variable in these CRTs. Ten CRTs
required access at individual level to routinely collected
data for primary outcome measurement. Individual
consent for data collection was not obtained for nine
(90%). Waivers for data access were reported for three
(33%). Adequacy of ethical processes to invite and
obtain informed consent for interventions and data
collection are context-specific. Whether transfer of deidentified data from routine clinical information systems
to researchers without prior individual consent is ethical
is highly dependent on stakeholder viewpoints (Weijer
et al 2011; Hey et al 2018; Lin et al 2021; de Hoop et
al 2015; London et al 2020). A systematic review by a
cross-cultural Australian team assessed the process of
seeking informed consent for research with Aboriginal
and Torres Strait Islander participants (Fitzpatrick et
al 2016). As such, these processes were confined to
individual RCTs. As concluded elsewhere by the same
research team (Fitzpatrick et al 2017; Fitzpatrick et al

2019), contemporary health and research designs can be
‘so complicated’ that informed consent can be difficult
for any researcher to facilitate and for any participant
to provide. Consent form construction in any context
requires a clear conceptualization of research purpose,
harms, benefits and procedures (Goldstein et al 2017).
Progress has certainly been made. In 2002, 44% of
Australian human research ethics committees reported
no procedures to include Aboriginal and Torres Strait
Islander people in reviewing Aboriginal and Torres Strait
Islander health research applications (Stewart et al 2006a;
Stewart et al 2006b). In 2021, there are five independently
constituted Aboriginal and Torres Strait Islander ethics
committees recognized by the NHMRC (2021). It
is imperative that local, regional and jurisdictional
perspectives for consent and waivers all must be
incorporated (Martin 2008; Studdert et al 2010; NAILSMA
2007; Lincoln et al 2017).
We also found that formal data and safety committees
or structures to oversight data access and data
interpretation were uncommon in these 18 CRTs.

Cultural authority
Third, our finding about impact on primary outcome
was intriguing but remains speculative. Across time and
place, CRTs are a resource-intensive design not always
delivering statistically significant results (Taljaard et al
2017; Siebenhofer et al 2018; Taljaard et al 2020; AlJaishi et al 2020; Prost et al 2015). If previous critique
of research generally undertaken in Australia affecting
Aboriginal and Torres Strait Islander peoples similarly
applies to CRTs (Jennings et al 2018; Bond et al 2021),
structural power imbalances and inadequate control
asserted by Aboriginal and Torres Strait Islander peoples
over design and implementation could similarly have
contributed to negative trial results. Unfortunately,
different approaches to decision-making and co-design
were incomplete in the majority of publications as
would be necessary to examine this with validity. Across
these 18 CRTs, governance to secure the necessary
cultural authority in research affecting Aboriginal and
Torres Strait Islander peoples varied. Where in place,
mechanisms ranged from advisory groups without clear
decision-making power over researchers to steering
committees with authority to co-design and, importantly,

maximize positive intervention impact. In research
publications, communities of any kind could be better
described in terms of their characteristics (particularly
their cohesiveness), the spectrum of ethical risks posed
to communities and individuals within them from
research and details about appropriate protections and
their effectiveness (Weijer et al 2000). In these 18 CRTs,
local ethical protocols also appeared to be in place but
not always, and not always unambiguously described to
assist understanding.

Self-reported ethical practices in subset
of SW-CRTs
It is noteworthy that seven (39%) of these 18 CRTs
had been designed and conducted as SW-CRTs. As a
design choice, SW-CRTs expose all clusters to untested
interventions by the end of the trial. SW-CRTs present
challenges for articulating equipoise, communicating the
rationale for the study choice and discussing risks with
potential participants when all clusters will be exposed
(Hey et al 2018). Unique ethical assessment is required for
the SW-CRT because its basic premise is

… that all clusters start in the control condition, and
they switch to the intervention condition in an order
determined by randomisation. SW-CRTs differ from
cluster crossover trials in that the switch is only in
one direction, from control to intervention condition
(Campbell et al 2019: 253).
As these and other authors also explain, SW-CRTs might
appeal to policy makers who wish to implement an
intervention under a strong but untested belief that it
will be beneficial yet the universal exposure of clusters
to an intervention not yet considered so beneficial that
its implementation should be universal might be a
contestable stance for public policy (Campbell et al 2019;
London et al 2020). Through randomization, SW-CRTs
expose every cluster (and individuals within it as a social
unit) to an intervention which may be ineffective, harmful
or beneficial however (Prost et al 2015). Seven CRTs
among these 18 CRTs were SW-CRTs. Debate continues.
Some justify the use of the SW-CRT design to ensure all
of a population receives the intervention at some point
while others are less comfortable with the unscientific

premise of this justification that requires an assumption
of inherent effectiveness rather than an assumption of
equipoise as the starting point for embarking on the trial
because research requires genuine uncertainty about
the benefits and harms of the intervention requiring
a randomized trial to resolve (see Mdege et al 2012;
Hemming et al 2019; Kotz et al 2012a; Kotz et al 2012b;
Prost et al 2015; Hargreaves et al 2015; Taljaard et al
2017; Al-Jaishi et al 2020). Abandoning equipoise as a
prerequisite for ethical experimental health and medical
research is problematic (Conrad & Edwards 2011). Use
of the SW-CRT is increasing, and the most commonly
cited reasons for choosing a SW-CRT are its perceived
logistical, social and ethical advantages (Hemming et
al 2020). Alternative designs may be preferable such as
a parallel CRT in which the control group is wait-listed
until results are known (Hemming et al 2020). These
alternative designs might also better address concerns
about statistical efficiencies, risks of bias and the impact
of secular changes.
Elsewhere, it has been recognized that large, expensive
and pragmatic trials such as SW-CRTs could be better
anchored to and reported against their intended purpose
(Nicholls et al 2020). This approach would encourage full
disclosure in study protocols of the purpose of the trial
in relationship to the policy or practice decisions that its
findings are intended to inform – and in which settings.
Providing this detail need not be ‘an aspirational ideal’ but
a ‘necessary component’ in research conceptualization
and protocol development (Nicholls et al 2020). Such
has been specifically recommended for SW-CRTs in
mainstream settings based on a comprehensive analysis
of ethical issues in two examples (Hemming et al 2019).
Detailed analysis of the decisional intent for policy or
practice in each of the seven SW-CRTs identified here
would be beneficial.

Methodological strengths and
limitations of this systematic review
The majority of these 18 CRTs were retrieved through
a replicable electronic search strategy which is a major
strength of this systematic review. Searching the ANZCTR
was a worthwhile addition to our search method. We
adapted robust data extraction methods to compile a
detailed overview of self-reported ethical practices. As

at February 2015, eleven SW-CRTs had been identified as
having been conducted in Australia as at February 2015
(Grayling et al 2017). Of these, two had been conducted
in Australian Aboriginal settings and both of these we
found through our own search strategy [EC2 and EC3].
Despite our confidence that we were unlikely to have
missed any CRT undertaken in Australia in Aboriginal
and Torres Strait Islander settings, we accept that this
systematic review was limited by the lack of resources
to contact authors directly for additional details
and to explore their views about ethical practices in
CRTs. For example, we could not explore whether
different ethical practices were implemented because
the majority or all of the respective lead researchers
at the level of Chief Investigator was Aboriginal or
Torres Strait Islander. Direct contact with researchers
to establish this was not undertaken and, as found, no
articles in our cohort indicated whether authors were
Aboriginal or Torres Strait Islander people. Others
have recommended consideration of the structural
and institutional characteristics aiding Aboriginal
and Torres Strait Islander community control in every
step of the research enterprise (Duke et al 2021). In a
Western epistemic paradigm, research is technically
completed once findings are produced and articles
written. For Indigenous researchers including
Aboriginal and Torres Strait Islander researchers for
whom their relationships to their communities brings
significant additional accountabilities, dissemination
requires a deeper reciprocity: ‘No matter how much
knowledge (or qualification) a person accumulates, if
the knowledge, research or stories do not reach the
collective consciousness of the wider group, then the
person is failing to act in an Indigenous manner’ (Xiiem
et al 2019:7). Systematically establishing the extent
of academic leadership of Aboriginal and Torres Strait
Islander researchers at the level of Chief Investigator
would permit a broader analysis of research impact
beyond the primary quantitative outcome measure for
each CRT considered here. In addition, our exclusive
focus here on changes in primary outcome measures
meant that we had no line of sight to changes in
secondary outcome measures. Secondary outcome
measures can provide useful insights about intervention
implementation, processes and surrogate endpoints
(Campbell et al 2012). As secondary outcome measures
are methodologically subservient to primary outcome

measures, our approach retains merit.
We also acknowledge that engaging researchers in an
initiative to share their research documents such as
research partnership contracts or the terms of reference
for advisory groups and steering committees would cast
complementary light on current practice and potentially
create a warehouse of practical examples. Further
enquiry would also lead to a better understanding
of researchers’ approaches to sampling frames and
recruitment strategies for clusters. Those CRTs in
our sample restricting participation to those clusters
with existing relationships with research teams have
strengths for research implementation but weaknesses
for generaliseability. Researchers’ reflections on these
trade-offs in CRTs and their ethical resolution would be
informative.
Most importantly, and to address the limitations of our
own positionality (Smith 2014), we welcome and would
support an open and iterative process to explore views of
Aboriginal and Torres Strait Islander peoples themselves
about these ethical complexities in CRTs. With Aboriginal
and Torres Strait Islander leadership of such an initiative,
a wide range of stakeholders could be consulted about
the ethical ground rules and requirements for in complex
designs such as the CRT. Others have initiated this scope
of enquiry in the context of consent (Lin et al 2021).

CONCLUSION
This is the first systematic review of ethical practices
in CRTs conducted in Australian Aboriginal and Torres
Strait Islander settings. As for all experimental research,
CRTs must have both sound methodological design
and ethical processes, such that the risk for harm is ‘…
reasonable in relation to the knowledge that may be
gained’ (Weijer & Miller 2004:571). When clusters such
as schools, health services, shops or entire communities
are randomized, unique ethical issues are introduced.
Ethical review is not straightforward. Nontherapeutic
harms for the ‘social unit’ may not be immediate, visible
or measurable. By contrast, individual RCTs where ethical
checks and balances including carefully delineated
consent procedures are generally much clearer. As a
baseline snapshot, variations in self-reported ethical
practices described in these 18 CRTs invite specific
effort to strengthen conceptualisation and conduct of

experimental trials in which large social units comprising
Aboriginal and Torres Strait Islander peoples or services
they receive are randomised. As at the time of writing,
there is no specific guidance from NHMRC or AIATSIS
about the unique ethical complexities of CRT designs in
these circumstances or recommendations for acceptable
ethical practices.
While international guidelines such as the Ottawa
Statement are useful, we are mindful of limitations
inherent in guidance put forward to support action
in Australia with consequences for Aboriginal and
Torres Strait Islander peoples yet developed without
Aboriginal and Torres Strait Islander perspectives and
control. This criticism has been raised in reference to
the development of the Ottawa Charter (McPhail-Bell
et al 2013). Continued use of the term ‘vulnerable
populations’ in any future re-issue of the Ottawa
Statement for CRT research may be somewhat discordant
in the Australian political context (Munari et al 2021).
Nonetheless, the Ottawa Statement remains to date the
only international guidance dedicated to ethical aspects
of CRTs. The findings of this systematic review are now
under active consideration by an independent Aboriginal
and Torres Strait Islander research ethics committee in
Australia whose direction we welcome for next steps
regarding guidelines specifically for future CRTs in such
settings. Aboriginal and Torres Strait Islander research
occurs in the context of a continuing ‘settler state’ in
which First Nations peoples have been and continue
to be systematically marginalized and disempowered.
There are unique ethical issues inherent in experimental
Aboriginal and Torres Strait Islander research particularly
when studies are led by or disproportionately
advantage non-Indigenous researchers: this continues
disempowerment and colonization (Pantazatos 2017;
Bond et al 2021; Manathunga et al 2021). Hence, there
may be interest in the citations, impact and implications
for policy and practice of the findings of each of these
CRTs as a means of gaining insight into epistemic justice
and research translation.
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